Drug Search Results
More Filters [+]

Fluconazole

Alternative Names: fluconazole, diflucan, zonal, fluzone, diflucan in sodium chloride 0.9% in plastic container, fluconazol
Latest Update: 2024-02-15
Latest Update Note: Clinical Trial Update

Product Description

Fluconazole is used to treat fungal infections, including yeast infections of the vagina, mouth, throat, esophagus (tube leading from the mouth to the stomach), abdomen (area between the chest and waist), lungs, blood, and other organs. Fluconazole is also used to treat meningitis (infection of the membranes covering the brain and spine) caused by fungus. Fluconazole is also used to prevent yeast infections in patients who are likely to become infected because they are being treated with chemotherapy or radiation therapy before a bone marrow transplant (replacement of unhealthy spongy tissue inside the bones with healthy tissue). Fluconazole is in a class of antifungals called triazoles. It works by slowing the growth of fungi that cause infection. (Sourced from: https://medlineplus.gov/druginfo/meds/a690002.html)

Mechanisms of Action: Cytochrome P450 Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intramuscular,Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Estonia | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Israel | Italy | Japan | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Sanofi
Company Location: PARIS I0 75008
Company CEO: Paul Hudson
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Fluconazole

Countries in Clinic: Australia, China, Germany, Japan, South Africa, Taiwan, Uganda, United Kingdom, United States, Unknown Location

Active Clinical Trial Count: 28

Highest Development Phases

Phase 3: Candidemia|Candidiasis, Invasive|Candidiasis, Oral|Candidiasis, Vulvovaginal|Influenza, Human|Meningitis, Cryptococcal

Phase 2: COVID-19|Hypercalciuria

Phase 1: Acute Pain|Bladder Cancer|Chronic Pain|Depressive Disorder|Healthy Volunteers|Low Back Pain|Lymphoma|Neuralgia|Oncology Unspecified|Pain, Postoperative|Respiratory Syncytial Virus Infections|Stroke|Urinary Calculi

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ACACIA

P3

Recruiting

Meningitis, Cryptococcal

2027-10-01

mRNA-1083-P101

P2

Active, not recruiting

Influenza, Human|COVID-19

2024-11-29

The FLUCOLITH study

P2

Active, not recruiting

Hypercalciuria

2024-05-14

D7420C00003

P1

Recruiting

Healthy Volunteers

2024-04-10

28%

D7420C00003

P1

Recruiting

Healthy Volunteers

2024-04-10

28%

D7420C00003

P1

Recruiting

Healthy Volunteers

2024-04-10

28%

D7420C00003

P1

Recruiting

Healthy Volunteers

2024-04-10

28%

Recent News Events